-
Comparison of opiate-primary treatment seekers with and without alcohol use disorder.
Hartzler B, Donovan DM, Huang Z. Comparison of opiate-primary treatment seekers with and without alcohol use disorder. Journal of Substance Abuse Treatment 2010;39(2):114-123.
-
Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy.
Brown ES, Tirado CF, Minhajuddin AT, Hillhouse M, Adinoff BH, Ling W, Doraimani G, Thomas G. Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy. Journal of Ethnicity in Substance Abuse 2010;9(2):106-114.
-
Alterations in brain structure and functional connectivity in prescription opioid-dependent patients.
Updahyay J, Maleki N, Potter JS, Elman I, Rudrauf D, Knudsen J, Wallin D, Pendse G, McDonald L, Griffin M, Anderson J, Nutile L, Renshaw P, Weiss RD, Becerra L, Borsook D. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain 2010;133(7):2098-2114.
-
The role of alcohol misuse in PTSD outcomes for women in community treatment: A secondary analysis of NIDA’s Women and Trauma study.
Hien DA, Campbell ANC, Ruglass LM, Hu M, Killeen T. The role of alcohol misuse in PTSD outcomes for women in community treatment: A secondary analysis of NIDA's Women and Trauma study. Drug and Alcohol Dependence 2010;111(1-2):114-119.
-
HIV risk behavior in treatment-seeking opioid-dependent youth: Results from a NIDA Clinical Trials Network multisite study.
Meade CS, Weiss RD, Fitzmaurice GM, Poole SA, Subramaniam GA, Patkar AA, Connery HS, Woody GE. HIV risk behavior in treatment-seeking opioid-dependent youth: Results from a NIDA Clinical Trials Network multisite study. Journal of Acquired Immune Deficiency Syndromes 2010;55(1):65-72.
-
A randomized controlled study of a web-based performance improvement system for substance abuse treatment providers.
Crits-Christoph P, Ring-Kurtz S, McClure B, Temes C, Kulaga A, Gallop R, Forman RF, Rotrosen J. A randomized controlled study of a web-based performance improvement system for substance abuse treatment providers. Journal of Substance Abuse Treatment 2010;38(3):251-262.
-
Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: A National Drug Abuse Treatment Clinical Trials Network study.
Wu L, Pan J, Blazer DG, Tai B, Stitzer ML, Woody GE. Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: A National Drug Abuse Treatment Clinical Trials Network study. Journal of Substance Abuse Treatment 2010;38(suppl 1):S70-S79.
-
Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: Secondary analyses from the Clinical Trials Network.
Potter JS, Chakrabarti A, Domier CP, Hillhouse M, Weiss RD, Ling W. Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: Secondary analyses from the Clinical Trials Network. Journal of Substance Abuse Treatment 2010;38(suppl 1):S80-S86.
-
Predicting outpatient treatment entry following detoxification for injection drug use: The impact of patient and program factors.
Campbell BK, Tillotson CJ, Choi D, Bryant K, DiCenzo J, Provost SE, Zammarelli L, Booth RE, McCarty D. Predicting outpatient treatment entry following detoxification for injection drug use: The impact of patient and program factors. Journal of Substance Abuse Treatment 2010;38(suppl 1):S87-S96.
-
Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs?
Nunes EV, Ball SA, Booth RE, Brigham GS, Calsyn DA, Carroll KM, Feaster DJ, Hien DA, Hubbard RL, Ling W, Petry NM, Rotrosen J, Selzer JA, Stitzer ML, Tross S, Wakim PG, Winhusen TJ, Woody GE. Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs? Journal of Substance Abuse Treatment 2010;39(suppl 1):S97-S112.